Surufatinib, gemcitabine, nab-paclitaxel: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Pancreatic cancer | 2 |
| Pancreatic Cancer Metastatic | 1 |
| Pancreatic Cancer, Adult | 1 |
Recruiting trials involving Surufatinib, gemcitabine, nab-paclitaxel
- A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer
- Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer
Common questions
How many recruiting trials involve Surufatinib, gemcitabine, nab-paclitaxel?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.